Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

July 4, 2020

An MRI-visible immunoadjuvant based on hollow Gd2 O3 nanospheres for cancer immunotherapy

Chemical Communications : Chem Comm
Xia LiAtsuo Ito
July 1, 2020
Review

Controlling timing and location in vaccines

Advanced Drug Delivery Reviews
Darrell J IrvineMurillo Silva
June 27, 2020
Open Access

SpeS: A Novel Superantigen and Its Potential as a Vaccine Adjuvant against Strangles

International Journal of Molecular Sciences
C Coral Dominguez-MedinaAndrew S Waller
July 1, 2020
Review
Open Access

Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection

Journal of Translational Medicine
Adam BrufskyMichael T Lotze
July 1, 2020

Cutting Edge: Inhibition of the Interaction of NK Inhibitory Receptors with MHC Class I Augments Antiviral and Antitumor Immunity

The Journal of Immunology : Official Journal of the American Association of Immunologists
Abir K PandaEthan M Shevach
July 4, 2020

Combined TLR4 and TLR9 agonists induce distinct phenotypic changes in innate immunity in vitro and in vivo

Cellular Immunology
Anna T LampeDeborah M Brown
July 1, 2020
Review
Open Access

Modulation of immune responses using adjuvants to facilitate therapeutic vaccination

Immunological Reviews
Virgil SchijnsEd C Lavelle
June 30, 2020
Preprint
Open Access

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice

BioRxiv : the Preprint Server for Biology
J.-H. TianGale Smith
June 28, 2020

TLR4 agonist protects against Trypanosoma cruzi acute lethal infection by decreasing cardiac parasite burdens

Parasite Immunology
L E Villanueva-LizamaK M Jones
June 27, 2020
Open Access

Plant virus particles with various shapes as potential adjuvants

Scientific Reports
Ekaterina A EvtushenkoOlga V Karpova
June 26, 2020
Review

TLR2 agonists and their structure-activity relationships

Organic & Biomolecular Chemistry
Benjamin L LuMargaret A Brimble
July 1, 2020

Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach

International Journal of Biological Macromolecules
Ishtiaque Ahammad, Samia Sultana Lira
June 28, 2020

Transcriptomic profiling of bovine blood dendritic cells and monocytes following toll-like receptor stimulation

European Journal of Immunology
G Tuba BarutStephanie C Talker

Sign up to follow this feed and discover related papers.

Related Feeds

AIDS Malignancies

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.

Bacillus Cereus Infection

Bacillus Cereus is a gram-positive bacteria that is the cause of some foodborne illnesses and leads to diarrhea and vomiting. Discover the latest research on Bacillus Cereus Infection here.

© 2020 Meta ULC. All rights reserved
/feed-previews/avian-influenza-innate-immune-adjuvant/d226f399-d030-4b51-bc0e-3765f2e6a991